INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $234,689 | +4.4% | 5,755 | -4.5% | 0.14% | -1.4% |
| Q1 2023 | $224,701 | +6.2% | 6,029 | -0.5% | 0.14% | +9.4% |
| Q4 2022 | $211,503 | -45.3% | 6,062 | -12.4% | 0.13% | -67.2% |
| Q3 2022 | $387,000 | +1.8% | 6,917 | -5.7% | 0.39% | +3.2% |
| Q2 2022 | $380,000 | -31.9% | 7,336 | -11.2% | 0.38% | -35.0% |
| Q1 2022 | $558,000 | +9.4% | 8,265 | +91.5% | 0.58% | +49.9% |
| Q4 2021 | $510,000 | -20.1% | 4,316 | -9.2% | 0.38% | -19.1% |
| Q3 2021 | $638,000 | -7.0% | 4,755 | +3.5% | 0.48% | -3.8% |
| Q2 2021 | $686,000 | +3.8% | 4,592 | -44.4% | 0.50% | -3.7% |
| Q1 2021 | $661,000 | +13.2% | 8,256 | -23.1% | 0.51% | +15.8% |
| Q4 2020 | $584,000 | – | 10,733 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |